Published in Gut on August 01, 2000
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis (2013) 1.65
Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy. Gut (2003) 1.40
Viral infections during pregnancy. Am J Reprod Immunol (2015) 1.17
Hepatitis C virus in pregnancy. Am J Perinatol (2013) 1.03
Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut (2002) 1.03
Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect Dis (2009) 1.01
Hepatitis C and pregnancy. World J Gastroenterol (2013) 0.94
Treatment of chronic hepatitis. BMJ (2001) 0.92
Vertical transmission of hepatitis C virus: Current knowledge and perspectives. World J Hepatol (2014) 0.89
Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis. Gut (2004) 0.87
Vertical hepatitis C virus transmission: Main questions and answers. World J Hepatol (2014) 0.85
Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review. BMC Public Health (2014) 0.84
Hepatitis C virus: laboratory surveillance in England and Wales, 1992-2004. Epidemiol Infect (2006) 0.83
Perinatal hepatitis C virus infection: diagnosis and management. Arch Dis Child (2006) 0.79
Exposure of healthcare workers to bloodborne viruses. Only the tip of the iceberg has been measured. BMJ (2001) 0.79
Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients. Infect Dis Obstet Gynecol (2003) 0.78
Increase in alcohol related deaths: is hepatitis C a factor? J Clin Pathol (2002) 0.78
Seroprevalence and risk factors of Hepatitis B and Hepatitis C infections among pregnant women in the Asante Akim North Municipality of the Ashanti region, Ghana; a cross sectional study. Afr Health Sci (2015) 0.78
Screening and shouting about HCV. Gut (2000) 0.77
Hepatitis C in pregnancy. Arch Dis Child Fetal Neonatal Ed (2001) 0.77
HCV and pregnancy: prevalence, risk factors, and pregnancy outcome in north Indian population: a case-control study. J Obstet Gynaecol India (2014) 0.76
Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women? BMJ Open (2016) 0.75
Hepatitis C virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis (2017) 0.75
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet (1995) 3.43
Hepatitis C virus infection in pregnancy. Br J Obstet Gynaecol (1996) 1.70
Hepatitis C: and miles to go before we sleep. N Engl J Med (1989) 1.67
Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ (1997) 1.24
The prevalence of hepatitis B and C in an antenatal population of various ethnic origins. Epidemiol Infect (1994) 1.20
Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Viral Hepat (1997) 1.14
Vertical transmission of hepatitis C virus in low-risk pregnant women. Eur J Clin Microbiol Infect Dis (1996) 0.89
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science (1991) 8.76
Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med (1995) 6.50
Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15
Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord (2001) 5.97
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut (2001) 3.45
A thermodynamic scale for the beta-sheet forming tendencies of the amino acids. Biochemistry (1994) 2.98
The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol (1996) 2.90
Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG (2008) 2.89
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J (1999) 2.71
An organic cause of neuropsychiatric illness in adolescence. Lancet (2003) 2.68
An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod (1994) 2.38
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ (2003) 2.34
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
System to detect tuberculosis in new arrivals to UK must be improved. BMJ (2000) 2.30
Protein alchemy: changing beta-sheet into alpha-helix. Nat Struct Biol (1997) 2.23
Increased post-operative haemorrhage seen in adult coblation tonsillectomy. J Laryngol Otol (2003) 2.16
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008) 2.06
The risks associated with pregnancy in women aged 35 years or older. Hum Reprod (2000) 2.06
Modular arrangement of functional domains along the sequence of an aminoacyl tRNA synthetase. Nature (1984) 2.04
Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet (1996) 2.01
Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem (1996) 1.92
Evidence for a cerebral effect of the hepatitis C virus. Lancet (2001) 1.90
Health-care provision for asylum seekers and refugees in the UK. Lancet (1999) 1.89
Guidelines for protein design: the energetics of beta sheet side chain interactions. Science (1995) 1.88
Refugees, asylum seekers, and general practice: room for improvement? Br J Gen Pract (2000) 1.80
Redesigning the hydrophobic core of a four-helix-bundle protein. Protein Sci (1994) 1.79
Impact of HIV infection on mortality in young men in a London health authority. BMJ (1992) 1.78
What makes a protein a protein? Hydrophobic core designs that specify stability and structural properties. Protein Sci (1996) 1.76
Recurrent miscarriage. BMJ (1991) 1.72
A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci U S A (2000) 1.70
Primary care in London: an evaluation of general practitioners working in an inner city accident and emergency department. J Accid Emerg Med (1996) 1.67
Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res (1991) 1.66
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold Des (1997) 1.57
Managing tuberculosis and HIV infection. BMJ (1992) 1.56
Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London. BJOG (2001) 1.53
Dissecting RNA-protein interactions: RNA-RNA recognition by Rop. Cell (1995) 1.53
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther (2010) 1.51
Teenage and adult tonsillectomy: dose-response relationship between diathermy energy used and morbidity. Clin Otolaryngol (2007) 1.45
Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol (2005) 1.44
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study. J Hepatol (2001) 1.42
Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum Reprod (2002) 1.42
Glucose production by the human placenta in vivo. Placenta (1999) 1.42
Novel metal-binding proteins by design. Nat Struct Biol (1995) 1.41
Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Clin Sci (Lond) (2002) 1.38
Facial burns due to fan heater. Br Med J (Clin Res Ed) (1981) 1.37
Dispensable pieces of an aminoacyl tRNA synthetase which activate the catalytic site. Cell (1984) 1.28
Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod (1997) 1.28
Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol (2009) 1.27
Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol (2000) 1.27
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Dramatic structural and thermodynamic consequences of repacking a protein's hydrophobic core. Structure (2000) 1.27
Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod (1996) 1.26
Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut (2005) 1.26
Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ (1997) 1.24
Amino-acid substitutions in a surface turn modulate protein stability. Nat Struct Biol (1996) 1.22
Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol (2006) 1.20
Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol (2001) 1.19
Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. Eur J Radiol (2006) 1.18
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod (2004) 1.16
Transmuting alpha helices and beta sheets. Fold Des (1997) 1.15
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat (2009) 1.14
Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril (2000) 1.13
Sidechain interactions in parallel beta sheets: the energetics of cross-strand pairings. Structure (1999) 1.13
Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology (1999) 1.12
Knowledge of chronic hepatitis C among East London primary care physicians following the Department of Health's educational campaign. QJM (2004) 1.11
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod (1999) 1.10
Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09
Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol (2003) 1.06
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod (2001) 1.05
British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm Infect (1999) 1.05
Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol (2001) 1.05
Effect of alteration of the acetic acid synthesis pathway on the fermentation pattern of escherichia coli. Biotechnol Bioeng (1991) 1.05
The role of backbone conformational heat capacity in protein stability: temperature dependent dynamics of the B1 domain of Streptococcal protein G. Protein Sci (2000) 1.04
Recurrent miscarriage--an aspirin a day? Hum Reprod (2000) 1.04
Understanding the sequence determinants of conformational switching using protein design. Protein Sci (2000) 1.04
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. Am J Gastroenterol (2004) 1.02
Polypeptide sequences essential for RNA recognition by an enzyme. Science (1987) 1.02
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. J Viral Hepat (2014) 1.01
Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01
Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia (2009) 1.01
Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01
Aromatic rescue of glycine in beta sheets. Fold Des (1998) 0.99
Characterization of metal binding by a designed protein: single ligand substitutions at a tetrahedral Cys2His2 site. Biochemistry (1995) 0.99
Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod (2002) 0.98
Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis (2010) 0.97
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol (1999) 0.96
Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod (2006) 0.95
Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem (1999) 0.95
Reproducibility of three-dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol (2003) 0.95
A further look at infection at the time of therapeutic abortion. Eur J Obstet Gynecol Reprod Biol (1990) 0.95
Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod (2000) 0.95
A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod (2003) 0.95
Neurodevelopmental outcomes in children with HIV infection under 3 years of age. Dev Med Child Neurol (2006) 0.95